Ozer Baysal - Agenus Insider

Agenus Inc -- Germany Stock  

EUR 4.46  0.23  4.90%

Chief Business Officer

Mr. Ozer Baysal is Chief Commercial Officer, Head of HR of Agenus Inc. Mr. Baysal was Chief Business Officer since January 2013 until July 1, 2017. Prior to joining Agenus Mr. Baysal spent more than 30 years with Pfizer in a broad number of functional and geographic areas, most recently serving as President of Europe, Emerging Markets Region. While at Pfizer, he held key leadership positions in Marketing, Sales, and Manufacturing, and was actively involved with numerous licensing and MA activities
Age: 60  Executive Since 2017      
781-674-4400  http://www.agenusbio.com
Baysal holds a bachelor degree from Bosphorus University in Industrial Engineering and has completed the Programs for Leadership and Management Development at Harvard Business School.

Management Efficiency

The company has return on total asset (ROA) of (39.63) % which means that it has lost $39.63 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (421.01) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 143.94 M in total debt. Agenus Inc has Current Ratio of 1.52 which is within standard range for the sector.

Entity Summary

Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the bodys immune system for patients suffering with cancer. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts. Agenus is traded on Frankfurt Stock Exchange in Germany.Agenus Inc (AJ81) is traded on Frankfurt Stock Exchange in Germany. It is located in 3 Forbes Road and employs 255 people.

Did you try this?

Run Portfolio Manager Now

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
Hide  View All  NextLaunch Portfolio Manager
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Agenus Inc to your portfolio

Top Management

Agenus Inc Leadership Team
Robert Stein, Executive, Ph.D
James Gorman, President
Ozer Baysal, Executive
Ulf Wiinberg, Director
Shalini Sharp, Director
Wadih Jordan, Director
Christine Klaskin, President
Garo Armen, Chairman, Ph.D
JeanMarie Cuillerot, Executive
Brian Corvese, Director
Andrea Rabney, Executive
Karen Valentine, President
Shahzad Malik, Director, Ph.D
Evan Ballantyne, CFO
Timothy Wright, Director

Stock Performance

Agenus Performance Indicators